Tertiapin Q
Product overview
		- Catalog Number
 - PPH08-1002
 
- Sequence
 - H-Ala-Leu-Cys-Asn-Cys-Asn-Arg-Ile-Ile-Ile-Pro-His-Gln-Cys-Trp-Lys-Lys-Cys-Gly-Lys-Lys-NH2
 
- Target
 - Tertiapin analog; Exhibits similar blocking activity as bee venom peptide tertiapin for Inward-Rectifier K+ Channel but has the advantage of increased stability due to replacement of Met by Gln, Occurs in honeybee venom
 
- Description
 - Tertiapin-Q is an oxidation-resistant mutant of the wild-type tertiapin where Methionine 13 has been replaced by a Glutamine. Tertiapin-Q blocks the inwardly rectifying Kir1.1 (ROMK1) and Kir3.1/3.4 (GIRK1/GIRK4 also known as IKACh) potassium channels with Kd values of around 2 nM and 8 nM respectively.Tertiapin-Q also inhibits calcium-activated large conductance BK potassium channels (KCa1.1) in a concentration and voltage-dependent manner (IC50 ~ 5 nM), in addition to inhibiting Kir3.1/3.2 (GIRK1/GIRK2) heteromultimer potassium channels with a Kd close to 270 nM. Tertiapin-Q can prevent dose-dependent acetylcholine(Ach)-induced atrioventricular blocks in mammalian hearts, as KCNJ3/KCNJ5 channels (also named I(KACh)), are activated by Ach found in mammalian myocytes. Tertiapin analog; Exhibits similar blocking activity as bee venom peptide tertiapin for Inward-Rectifier K+ Channel but has the advantage of increased stability due to replacement of Met by Gln. Host: Bee Venom. Trifluoroacetate Salt. C106H175N35O24S4. CAS: 252198-49-5. Disulfide Bonds: Cys3-Cys14, Cys5-Cys18
 
			Category		
				Product Properties
		| Quantity | 1mg, 5mg  | 
		
|---|---|
| Storage | Shipped at 4°C. Store at -20°C for one year.  | 
		
| Purity | > 95%  | 
		
| Source | Synthetic  | 
		
| Forma appearance | Lyophilized powder  | 
		
- For research use only
 - Not for use in diagnostic procedures
 
€622,00 – €2.548,00 Tax excluded
			Contact us to request price here		
				
			Register to buy peptides 		
				Contact us